March 05, 2018

Tuberculosis (TB) Testing Capabilities

State-of-the-art technologies, quality management systems, and high-quality infrastructure to address the full spectrum of your clinical trial TB testing needs
Q2 Solutions has a full service Central Laboratory in Pretoria, South Africa with a dedicated Biosafety Level 3 Tuberculosis (TB) testing Lab.

With over 35 years of experience in infectious disease and immunology assay development and clinical diagnostic testing, our scientific experts are ready to partner with you to develop the right assay for your TB testing needs.

Download our infographic to learn more about how we can help you in the development of treatment, vaccines, and diagnostics for clinical trial tuberculosis testing.

Related Services:
Q2 Solutions Anti-infective and Vaccine Development Services

Delivery Excellence for Anti-infective and Vaccine Development

Supply chain and quality management systems to ensure sample integrity for high-quality data delivery

Keeping Up with the Flu: Advances in seasonal influenza vaccine development

Vaccine Laboratory Services

Test Menu

Harnessing innovative technologies for clinical trials involving emerging and re-emerging infectious diseases

Tools for better management of infectious disease clinical trials

Zika Vaccine Research: Complex Steps Toward a Critical Need

Overcoming Zika vaccine development challenges

Read More